Pregnancy-related risks impact childbearing decisions for meningioma survivorsOncology Nurse Advisor – Feb. 11Researchers from Moffitt Cancer Center in Tampa, Florida, developed a survey to identify the impact of a meningioma diagnosis on women’s views about reproductive choices. In a preliminary study, the researchers surveyed women who had received a diagnosis of meningioma to ascertain their personal attitudes toward childbearing and what influences, such as physician recommendations, may have played a role in these attitudes.

SHOP TALKOncology Times – Feb. 10Lodovico Balducci, MD, Senior Adult Oncology Program leader at Moffitt Cancer Center, has received the fifth annual Enzo Piccinini Prize from the Enzo Piccinini Foundation in partnership with the University of Modena and Reggio Emilia School of Medicine in Italy.

Tanglewood residents Golf Fore A CureHighlands Today – Feb. 10140 golfers took part in the 10th and final “Golf Fore A Cure” tournament held on the Turtle Run course at the Sun ‘n Lake Golf Club on Sunday. The money raised will go for breast cancer research at the Moffitt Cancer Center in Tampa.

Moffitt Cancer Center Reports on Faculty Participants in International Discovery of Genetic Risk Factors for Ovarian CancerThe ASCO Post – Feb. 10Researchers from Moffitt Cancer Center in Tampa, Florida have participated in a global effort that has identified six new regions of the genome that increase risk of epithelial ovarian cancer, according to a news release from Moffitt. The collaborative study was published recently in Nature Genetics. The study is unique in that it includes a combined analysis of two groups of women who had their genetic profiles completed as part of a large international collaboration.

Therapy offers hope for advanced melanomaDermatology Times – Feb. 9Nivolumab , a newly developed checkpoint protein inhibitory antibody directed against programmed death-1, or PD-1, with significant clinical activity against melanoma, can treat other malignancies outside of melanoma and renal cell carcinoma, which is one of the big advances with the treatment, according to Jeffrey Weber M.D., Ph.D., senior member of the H. Lee Moffitt Cancer Center, and director, Donald A. Adam Comprehensive Melanoma Research Center in Tampa Bay, Fla.

In Puerto Rico, Health Overhaul Gets An IncompleteNPR “Shots” blog (Health News from NPR) – Feb. 7A few months later, he had the procedure performed at the Moffitt Cancer Center in Tampa, Florida. He took his two young kids, ages two and six, to Disney World to celebrate. Now he’s back in San Juan selling cars, and continuing his chemotherapy. He says he feels great.

Column: U.S. risks falling behind in medical research (w/video)Tampa Bay Times – Feb. 6At its infancy 20 years ago, H. Lee Moffitt Cancer Center & Research Institute in Tampa had only one research scientist overseeing a small lab. Today, more than 800 Moffitt scientists research ways to prevent and treat cancer in one of the most advanced National Cancer Institute Comprehensive Cancer Centers in the country.

Dabrafenib/Trametinib Combo Continues to Show BenefitOncLive – Feb. 6In an interview with OncLive, Jeffrey S. Weber, MD, PhD, a senior member at Moffitt Cancer Center, said that dabrafenib plus trametinib has proven to be efficacious but that other oncologists doubt the curative potential of a BRAF/MEK combination and treat with immunotherapy first.

Candidates get rid of excess campaign cash in many waysNews-Press.com – Feb. 6The group of about 30 starts in Tampa on Feb. 14, ending in Tallahassee where they’ll meet with legislators to promote state funding for the Moffitt Cancer Center. They’re also soliciting individual donations from friends and associates. Aubuchon lost both parents to cancer, so the cause is important to him.

Patient Voices Essential, as Docs Underreport ToxicitiesMedscape – Feb. 5“This study documents the gap between patient-reported and clinician-reported adverse reactions,” said Andy Trotti, MD, from the Moffitt Cancer Center in Tampa, Florida. “It is not surprising that there are differences,” he told Medscape Medical News. “The next step is converting patient-reporting of the most relevant events that are study-specific directly into common terminology criteria as a routine practice in clinical trials.”

###

Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.

Request an Appointment at Moffitt Cancer Center

Thank you for your interest in scheduling an appointment with our expert team. Please call us at 1-888-663-3488 and a patient services specialist can assist you with scheduling or click on one of the links below to fill out our convenient online form.

NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.

RETURNING PATIENTS Since you are an established Moffitt patient, please call us directly to schedule your follow-up appointment at 1-888-663-3488.